Search results

Publication date Communities Collections Article title Author(s) Journal/Conference
29 Dec 2015 BMRC Bioprocessing Technology Institute Use of a novel cytotoxic HEXIM1 peptide in the directed breast cancer therapy Shu Hui Neo, Qiao Jing Lew, Ser Mei Koh, Lu Zheng, Xuezhi Bi, Sheng-Hao Chao Oncotarget
16 Nov 2014 BMRC Bioprocessing Technology Institute GCN5 inhibits XBP-1S-mediated transcription by antagonizing PCAF action Qiao Jing Lew, Kai Ling Chu, Yi Ling Chia, Benjamin Soo, Jia Pei Ho, Chew Har Ng, Hui Si Kwok, Cheng-Ming Chiang, Yao Chang, Sheng-Hao Chao Oncotarget
29 Jan 2014 BMRC Bioprocessing Technology Institute Brd4 and HEXIM1: Multiple Roles in P-TEFb Regulation and Cancer Ruichuan Chen, Jasper H. N. Yik, Qiao Jing Lew, Sheng-Hao Chao BioMed Research International
5 Oct 2013 BMRC Bioprocessing Technology Institute Inhibition of human cytomegalovirus replication by overexpression of CREB1 Yi Ling Chia, Chew Har Ng, Philip Lashmit, Kai Ling Chu, Qiao Jing Lew, Jia Pei Ho, Hsueh Lee Lim, Peter Morin Nissom, Mark F. Stinski, Sheng-Hao Chao Antiviral Research
20 Aug 2013 BMRC Bioprocessing Technology Institute HEXIM1 Induces Differentiation of Human Pluripotent Stem Cells Vanessa Ding, Qiao Jing Lew, Kai Ling Chu, Subaashini Natarajan, Vikneswari Rajasegaran, Meera Gurumurthy, Andre B. H. Choo, Sheng-Hao Chao, Austin John Cooney PLoS ONE